Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
36 hedge funds and large institutions have $48.5M invested in Intermolecular, Inc. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
16% more funds holding
Funds holding: 31 → 36 (+5)
13% more capital invested
Capital invested by funds: $43M → $48.5M (+$5.46M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
+$1.19M |
| 2 |
Renaissance Technologies
New York
|
+$169K |
| 3 |
SIM
Spark Investment Management
New York
|
+$164K |
| 4 |
SPM
Symmetry Peak Management
Radnor,
Pennsylvania
|
+$135K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$117K |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$72K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$61K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$52.2K |
| 5 |
RA
Royce & Associates
New York
|
-$47.9K |
IMI Hedge Fund Activity: Q1 2016 in Review
36 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q1 2016, worth a combined $48.5M — up 13% from $43M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IMI positions and 3 closed out — a net gain of 5 holders — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Cowen Prime Advisors, adding an estimated $1.19M. The largest seller was 683 Capital Management, cutting an estimated $117K.
- 36 institutional investors held Intermolecular, Inc. (IMI) as of Q1 2016, up from 31 in Q4 2015.
- Funds reported $48.5M of Intermolecular, Inc. stock for Q1 2016, up 13% quarter-over-quarter.
- 8 funds opened new Intermolecular, Inc. positions in Q1 2016 and 3 closed out, a net change of +5 holders.
- The largest Intermolecular, Inc. buyer in Q1 2016 was Cowen Prime Advisors, an estimated $1.19M added.
- The largest Intermolecular, Inc. seller in Q1 2016 was 683 Capital Management, an estimated $117K sold.
Based on aggregated 13F filings for Q1 2016.